Melanoma antigen peptide and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8975371
SERIAL NO

14086067

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel melanoma antigen peptides and specific T lymphocytes directed to said peptides and the use thereof for treating melanoma.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NANTES UNIVERSITÉ1 QUAI DE TOURVILLE NANTES 44000

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Godet, Yann Nantes Cedex, FR 2 1
Labarriere, Nathalie Nantes Cedex, FR 6 5
Moreau-Aubry, Agnes Nantes Cedex, FR 2 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 10, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00